16.7 C
New York
Saturday, October 5, 2024

Buy Now

Things we should know

Reading Time: < 1 minute

“Many of the problems with Moderna that Garde identified in 2016 continued to plague the company right up until the beginning of the COVID-19 crisis. Chief among these was Moderna’s struggle to prove that its technology worked and that it was safe. Concerns about the safety and efficacy of the company’s products, which were publicly reported beginning in 2017, evaporated in the wave of panic surrounding COVID-19 and the simultaneous “Warp Speed” race for a vaccine that would “end the pandemic.” Yet, there is little, if any, evidence that these once-well-recognized concerns were addressed before the US government’s emergency use authorization of Moderna’s COVID-19 vaccine and its now widespread use in many countries around the world. To the contrary, there is evidence that these concerns were covered up both before and during the development of its vaccine.” Moderna: A Company “In Need of A Hail Mary” by Whitney Webb 

**********

Thank you for reading Junious Stanton’s article on scoopnewsusa.com. For more on “Things we should know”, please subscribe to SCOOP USA Media. Print subscriptions are $75 and online subscriptions (Print, Digital, and VIZION) are $90. (52 weeks / 1 year).

Previous article
Next article

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

1,193FansLike
154FollowersFollow
0SubscribersSubscribe

Latest Articles